First human trial for stem cell hearing loss treatment
The UK just approved a first-of-its-kind trial testing Rincell-1, a stem cell therapy that could actually repair hearing—not just manage it.
Twenty people getting cochlear implants at three hospitals will take part, targeting the most common type of permanent hearing loss worldwide.
How Rincell-1 works
Rincell-1 uses special cells to fix damaged nerves in the ear, helping sound signals reach the brain again.
The study splits patients into groups: some get both Rincell-1 and implants, others get only implants, so researchers can see what really works.
Study's results expected within a year
If successful, this could be a game-changer for over a billion people living with hearing loss.
Unlike current treatments that just help you cope, Rincell-1 aims to restore actual function—offering real hope for healthier aging and better quality of life.
Results are expected within a year.